Previous Episode: SMCNS 1 2009 | Case 9
Next Episode: SMCNS 1 2009 | Case 7

62-yo man w/GBM receives 1st-line cilengitide, currently enrolled on double-blind randomized trial of lomustine with/without cediranib for recurrent GBM. Moderated by Neil Love, MD. Produced by Research To Practice.